Table 3 Prognostic factors associated with overall survival in cohort 1 using univariate and multivariable analyses (N = 378).
Prognostic factors | Univariate analyses | Multivariate analysis | ||
|---|---|---|---|---|
Unadjusted HR (95% CI) | P | Adjusted HR (95% CI) | P | |
Gender (Female vs. Male) | 1.038 (0.829~1.299) | 0.746 | ||
Age (≥65 vs. <65) | 1.083 (0.866~1.355) | 0.484 | ||
Tumor stage (IV vs. III) | 5.441 (2.687~11.020) | <0.001 | 5.154 (2.409~10.03) | <0.001 |
Primary tumor site | 0.880 (0.792~0.977) | 0.016 | 0.993 (0.893~1.104) | 0.896 |
Palliative care (PCR vs. BSC) | 0.432 (0.328~0.569) | <0.001 | 0.630 (0.468~0.847) | 0.002 |
Family history (Yes vs. No) | 1.174 (0.921~1.498) | 0.195 | ||
Smoke history (Yes vs. No) | 0.856 (0.663~1.105) | 0.233 | ||
Nutrient (Abnormal vs. Normal) | 1.732 (1.336~2.246) | <0.001 | 1.141 (0.866~1.502) | 0.349 |
Concomitant disease (Yes vs. No) | 1.016 (0.810~1.275) | 0.891 | ||
Hospital stay (≤14 vs. >14 days) | 0.995 (0.794~1.246) | 0.962 | ||
Albumin level | 0.943 (0.926~0.960) | <0.001 | 0.956 (0.937~0.976) | <0.001 |
NLR (HNLR vs. LNLR) | 1.377 (1.049~1.806) | 0.020 | 1.514 (1.125~2.038) | 0.006 |
